Rejuvenate Bio banks $10M to advance gene therapy for aging in humans and dogs

This is a funding announcement, not a completed medical study. A biotechnology company raised $10 million to develop gene therapy, which means changing genes to try to treat disease or aging. The work was planned for dogs and eventually humans. The report gives no treatment results, participant numbers, or proof that the approach works.

What this means for you: This does not show that gene therapy can slow aging in people or dogs. There is nothing here to buy or use, and you can ignore this as evidence of an effective anti-aging treatment.